What's breaking now, across thousands of outlets.
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
South Africa’s first generic semaglutide injection arrived in August, with many more expected. More competition should push down the price of blockbuster GLP-1 drugs – but will they become cheap…
Cancer patients living on the Costa del Sol could potentially access an advanced treatment using their own immune cells, with […]
Ebola is a disease that spreads through communities, so we need to listen to communities if we want to halt its spread Each time we travel to the Democratic Republic of the Congo (DRC), we go first to…
This podcast explores how leading Alzheimer’s experts are working to bridge the gap between clinical trial design and frontline care.
Trump administration finalized rule to end Medicaid support for care including hormones and speech therapy New Mexico will continue funding gender-affirming care for minors after a federal rule ending…
When temperatures rise, the brain's hypothalamus works overtime to regulate body heat. This intensive thermoregulation demands significant physiological resources, leaving individuals with reduced…
